300254 仟源醫藥
按盤價 
9.540 +0.660 (+7.432%)
9.540 +0.660 (+7.432%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.136 | 7.675 | 8.947 | 4.288 | -20.358 |
| 總資產報酬率 ROA (%) | 0.270 | 1.558 | 2.831 | 1.670 | -7.619 |
| 投入資產回報率 ROIC (%) | 0.375 | 2.361 | 4.020 | 2.145 | -9.679 | 邊際利潤分析 |
| 銷售毛利率 (%) | 66.403 | 67.382 | 66.908 | 67.788 | 69.735 |
| 營業利潤率 (%) | 2.794 | 9.161 | 7.677 | 5.024 | -13.883 |
| 息稅前利潤/營業總收入 (%) | 8.857 | 12.897 | 11.391 | 10.612 | -5.669 |
| 淨利潤/營業總收入 (%) | 3.330 | 6.481 | 8.830 | 6.096 | -11.812 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 57.511 | 95.210 | 67.396 | -7.070 | 73.038 |
| 價值變動淨收益/利潤總額(%) | -15.500 | -16.480 | 5.635 | 37.776 | 3.811 |
| 營業外收支淨額/利潤總額(%) | 48.776 | 12.135 | 19.405 | 27.361 | -27.853 | 償債能力分析 |
| 流動比率 (X) | 0.997 | 0.979 | 0.877 | 0.963 | 0.847 |
| 速動比率 (X) | 0.664 | 0.763 | 0.645 | 0.676 | 0.675 |
| 資產負債率 (%) | 65.526 | 63.818 | 61.351 | 45.681 | 53.945 |
| 帶息債務/全部投入資本 (%) | 43.475 | 52.252 | 44.108 | 35.984 | 48.279 |
| 股東權益/帶息債務 (%) | 86.254 | 53.565 | 76.461 | 154.168 | 93.972 |
| 股東權益/負債合計 (%) | 44.894 | 29.060 | 36.122 | 91.673 | 67.268 |
| 利息保障倍數 (X) | 2.603 | 5.221 | 6.106 | 2.871 | -1.093 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 95.945 | 73.539 | 54.490 | 47.106 | 49.507 |
| 存貨周轉天數 (天) | 233.096 | 168.378 | 162.948 | 156.661 | 151.840 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
